Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT

被引:1
|
作者
Lee, Sang Ho [1 ,2 ]
Hayano, Koichi [3 ]
Sahani, Dushyant V. [3 ]
Zhu, Andrew X. [4 ,5 ]
Yoshida, Hiroyuki [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiol, Imaging Res 3D, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Radiol, Div Abdominal Imaging & Intervent, Boston, MA 02114 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med,Dept Med,Div Hematol & Oncol, Boston, MA 02114 USA
[5] Dana Farber Partners Canc Care, Boston, MA 02114 USA
来源
ABDOMINAL IMAGING: COMPUTATIONAL AND CLINICAL APPLICATIONS | 2014年 / 8676卷
关键词
Hepatocellular carcinoma; Antiangiogenic treatment; Kinetic texture; Perfusion CT; COLORECTAL-CANCER; INITIAL-EXPERIENCE; ENHANCEMENT; BEVACIZUMAB; PARAMETERS; TRACER; TISSUE; LIVER; MODEL; MRI;
D O I
10.1007/978-3-319-13692-9_5
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Previous texture analysis studies of liver CT images have shown the potential to achieve hepatic malignancy or predict overall survival (OS). However, to date, most studies have mainly focused on assessing texture features of the non-contrast CT or portal-phase image in the dynamic contrast-enhanced CT sequence. The aim of this study was to quantify texture features of physiologically-based kinetic parametric images, and to develop prognostic kinetic textural biomarkers for 1-year survival (1YS) and OS in patients with advanced hepatocellular carcinoma (HCC) following antiangiogenic therapy in comparison among five different tracer kinetic models. Mean, standard deviation, coefficient of variation, skewness, and kurtosis of the pixel distribution histogram within HCC were derived from baseline first-pass perfusion CT parameters. Results suggest that texture analysis of kinetic parametric images can provide better chances of finding effective prognostic biomarkers for the prediction of survival than a mean value analysis alone.
引用
收藏
页码:48 / 61
页数:14
相关论文
共 10 条
  • [1] Use of Tracer Kinetic Model-Driven Biomarkers for Monitoring Antiangiogenic Therapy of Hepatocellular Carcinoma in First-Pass Perfusion CT
    Lee, Sang Ho
    Hayano, Koichi
    Sahani, Dushyant
    Yoshida, Hiroyuki
    ABDOMINAL IMAGING: COMPUTATION AND CLINICAL APPLICATIONS, 2013, 8198 : 270 - 279
  • [2] Advanced Hepatocellular Carcinoma: Perfusion Computed Tomography-Based Kinetic Parameter as a Prognostic Biomarker for Prediction of Patient Survival
    Lee, Sang Ho
    Hayano, Koichi
    Zhu, Andrew X.
    Sahani, Dushyant V.
    Yoshida, Hiroyuki
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2015, 39 (05) : 687 - 696
  • [3] Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST)
    Jiang, Tao
    Kambadakone, Avinash
    Kulkarni, Naveen M.
    Zhu, Andrew X.
    Sahani, Dushyant V.
    INVESTIGATIVE RADIOLOGY, 2012, 47 (01) : 11 - 17
  • [4] CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy
    Liu, Ying
    Wei, Xiaoqin
    Zhang, Xinrui
    Pang, Caifeng
    Xia, Mingkai
    Du, Yong
    TRANSLATIONAL ONCOLOGY, 2022, 26
  • [5] A CT-Based Clinical-Radiomics Nomogram for Predicting the Overall Survival to TACE Combined with Camrelizumab and Apatinib in Patients with Advanced Hepatocellular Carcinoma
    Ding, Guangyao
    Li, Kailang
    ACADEMIC RADIOLOGY, 2025, 32 (04) : 1993 - 2004
  • [6] Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 733 - 739
  • [7] 13N-Ammonia PET-CT for Evaluating Response to Antiangiogenic Therapy and Prognosis in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
    Scolozzi, Valentina
    Nicoletti, Alberto
    Capotosti, Amedeo
    Ponziani, Francesca Romana
    Taralli, Silvia
    Genco, Enza
    Leccisotti, Lucia
    Moretti, Roberto
    Indovina, Luca
    Pompili, Maurizio
    Calcagni, Maria Lucia
    CANCERS, 2025, 17 (04)
  • [8] Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis
    Gao, Yang
    Wang, Peng-Xiang
    Cheng, Jian-Wen
    Sun, Yun-Fan
    Hu, Bo
    Guo, Wei
    Zhou, Kai-Qian
    Yin, Yue
    Li, Yuan-Cheng
    Wang, Jian
    Huang, Jun-Feng
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    Yang, Xin-Rong
    CANCER MEDICINE, 2019, 8 (16): : 6933 - 6944
  • [9] An interpretable ensemble model combining handcrafted radiomics and deep learning for predicting the overall survival of hepatocellular carcinoma patients after stereotactic body radiation therapy
    Chen, Yi
    Pasquier, David
    Verstappen, Damon
    Woodruff, Henry C.
    Lambin, Philippe
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [10] General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy
    Tada, Toshifumi
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Mori, Nami
    Tsuji, Keiji
    Hasebe, Chitomi
    Joko, Koji
    Akahane, Takehiro
    Furuta, Koichiro
    Kobashi, Haruhiko
    Fujii, Hideki
    Ishii, Toru
    Marusawa, Hiroyuki
    Kondo, Masahiko
    Kojima, Yuji
    Yoshida, Hideo
    Uchida, Yasushi
    Nakamura, Shinichiro
    Izumi, Namiki
    JGH OPEN, 2022, 6 (07): : 487 - 495